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Aspen Medical, Deakin, NSW, Australia
Background: The 17th World Transplant Games occurred
n the Gold Coast, Australia August 22 to 30, 2009, at the
nd of the winter season in the southern hemisphere. Due to
oncerns related to the virus and after 4 countries withdrew
ltogether, a mandatory screening process and inﬂuenza
linic was instituted to assist in the health and safety of
he participants. This review outlines the procedure and
utcomes of this process.
Methods: Screening consisted of a medical questionnaire
nd tympanic temperature scan, conducted by 4 nurses
nd 2 doctors. Positive symptoms and/or a temperature
37.5 C (99.5.F) were referred for physician assessment. The
inaxNOW test kit (Inverness Medical, Maine USA) was used
or the rapid diagnosis of inﬂuenza A. Screening attendance
as cross referenced with the registration database, and
ndividual team managers helped reinforce screening com-
liance and isolation processes.
Results: A total of 2125 individuals presented for screen-
ng over a 2.5 day period, arriving from over 45 countries.
nly 8 registered athletes and supporters failed to attend
or screening however 29.4% of the volunteer group failed to
ttend screening and 7.5% of volunteers did not register for
he Games altogether. Only 0.5% of attendees required fur-
her medical evaluation. Of these, 68 people were deemed
o have had a mild viral illness of either respiratory or gas-
rointestinal origin. 31 people were swabbed nasally and
ll returned a negative result with the BinaxNOW Rapid
nﬂuenza test, 7 were clinically deemed non infectious, 14
ere placed in home isolation for 48 hours, treated con-
ervatively and medically reassessed, 9 were prescribed
nﬂuenza prophylaxis and 7 convention centre staff were
nstructed to take a medical leave of absence until symp-
oms resolved. Separate to this process, just fewer than
0% of participants were prescribed inﬂuenza prophylaxis
y their regular physicians. This practice varied by country
nd by registration status.
Conclusion: The screening process was limited by time
onstraints and volunteer compliance. No documented cases
f H1N1 09 were identiﬁed during the Games; however 25
onservatively treated upper respiratory viral illnesses were
anaged in the clinic.
oi:10.1016/j.ijid.2010.02.1703
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pidemiology of severe pediatric patients with novel
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f
Background: Since the ﬁrst outbreak of novel inﬂuenza
(H1N1) in May 2009, the virus has been spread through-
ut local communities. More than 4,000 diagnosed cases
re being reported daily as of November 2009. One of the
ajor infection routes is the educational institutions, so
hildren and teenagers have high risk of viral exposure.
orea Centers for Disease Control and Prevention (KCDC)
s operating nationwide monitoring system for severe hos-
italization cases. The objective of this study is to highlight
emographics, infection risk factors and clinical courses.
Methods: Inﬂuenza A (H1N1) patients who were hospital-
zed in ICU or had pneumonia in needs of intubation were
ategorized as severe pediatric patients. Between June and
ctober, total of 22 cases under the age of 18 were identiﬁed
s severe patients. After the medical chart review, we had
n interview with the doctor in charge. All the patients were
aboratory-conﬁrmed inﬂuenza A (H1N1) virus infection by
eans of real-time PCR. Based on the Advisory Commit-
ee on Immunization Practices, the patients with high-risk
edical conditions were deﬁned as having higher risk for
nﬂuenza complications.
Results: Among the reported 22 severe cases, 15 were
ale and 7 were female. Ages ranged from 2 months to
8 years old (median 7, standard deviation 5.4). Fourteen
atients (63%) had high-risk medical conditions such as 1)
ge less than 59 months (6 cases), 2) chronic respiratory dis-
ase (3 asthma cases), 3) neuro-developmental disorder (3
ases), 4) congenital heart disease (1 case) and 5) leukemia
1 case). Total of 7 patients have expired. Patients took
nti-viral agent (Tamiﬂu®) average 2 days after onset. Thir-
een patients received ventilator care, 7 did not and 2 were
nsure. Viral pneumonia was the most common complica-
ion (17 cases, 77%) and 3 patients exacerbated into acute
espiratory distress syndrome. Initial symptoms were fever
nd cough (18 cases, 81% each). There were 11 leukocyto-
is, 3 leucopenia and 3 thrombocytopenia cases on complete
lood count.
Conclusion: Half of patients with high-risk medical condi-
ions have expired. Considering current situations, we need
o maintain high-risk medical conditions category and to
ave continuous tracking for severe pediatric patients with
nﬂuenza A (H1N1).
oi:10.1016/j.ijid.2010.02.1704
